Who We Are

Turning biological barriers into bridges

Zippin Bio was founded in 2023 by Mahsa Khoshbakht and Omid Sadeghi, whose expertise spans chemistry, genetic modifications, and translational research. Motivated by the challenges of delivering therapeutics across the blood–brain barrier, they set out to address a key bottleneck in treating CNS diseases.
Rather than focusing solely on drug discovery, they envisioned a platform to improve the success of therapies that traditionally cannot reach the brain. Today, Zippin Bio brings together a multidisciplinary team of scientists and engineers translating this platform into scalable solutions, with the goal of redefining how therapeutics cross biological barriers.

Meet the Team

  • Mahsa Khoshbakht, PhD

    CEO, FOUNDER

    More Info

  • Douglas Keszler, PhD

    CHIEF STRATEGY OFFICER

    More Info

  • Omid Sadeghi, PhD

    EXECUTIVE CHAIRMAN, FOUNDER

    More Info

  • Valeriia Stepanova, MS

    RESEARCH SCIENTIST

    More Info